Advertisement

CardioVascular and Interventional Radiology

, Volume 41, Issue 10, pp 1573–1578 | Cite as

Infectious Outcomes from Renal Tumor Ablation: Prophylactic Antibiotics or Not?

  • Daniel Crawford
  • Eric vanSonnenbergEmail author
  • Paul Kang
Clinical Investigation Non-Vascular Interventions
Part of the following topical collections:
  1. Non-Vascular Interventions

Abstract

Introduction

Variability exists among institutions and physicians regarding the use of prophylactic antibiotics for ablation of renal tumors. The literature was reviewed for infectious complications vis-à-vis the reported use of prophylactic antibiotics for tumor ablation of renal neoplasms.

Materials and Methods

PubMed was searched for articles reporting radiofrequency ablation, cryoablation, and microwave ablation of renal masses, both by percutaneous and laparoscopic approaches. Data regarding potentially infectious outcomes, prophylactic antibiotic use or not, patient information, lesion characteristics, and procedural specifics were extracted from relevant articles.

Results

Fifty-one articles met the inclusion criteria. Potentially infectious complications occurred in 74/6952 patients (1.06%) if fever is included, but only 29 patients (0.42%) if fever is excluded. Prophylactic antibiotics were reported in 373 patients and were not mentioned in 6579 patients. The incidence of fever was higher with the laparoscopic radiofrequency ablation and cryoablation compared to the percutaneous approach (p < 0.001).

Conclusion

Prophylactic antibiotics seldom are used and/or reported in renal tumor ablation, and when they are, the antibiotic regimens vary widely. Even so, infectious complications in renal tumor ablation are uncommon. The similar and very low rates of infectious outcomes among ablation types and the two access approaches (laparoscopic and percutaneous) suggest that prophylactic antibiotics for routine renal tumor ablation are unnecessary.

Keywords

Ablation Radiofrequency ablation Cryoablation Microwave ablation Renal tumors Kidney cancer 

Notes

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics Approval

For this type of study formal consent is not required. This article does not contain any studies with human participants or animals performed by any of the authors.

Supplementary material

270_2018_2043_MOESM1_ESM.docx (99 kb)
Supplementary material 1 (DOCX 99 kb)

References

  1. 1.
    Shin BJ, Chick JFB, Stavropoulos SW. Contemporary status of percutaneous ablation for the small renal mass. Curr Urol Rep. 2016;17:1–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Venkatesan AM, Wood BJ, Gervais DA. Percutaneous ablation in the kidney. Radiology. 2011;261:375–91.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Venkatesan AM, Kundu S, Sacks D, et al. Practice guideline for adult antibiotic prophylaxis during vascular and interventional radiology procedures. J Vasc Interv Radiol. 2010;21:1611–30.CrossRefPubMedGoogle Scholar
  4. 4.
    Krokidis ME, Orsi F, Katsanos K, Helmberger T, Adam A. CIRSE guidelines on percutaneous ablation of small renal cell carcinoma. Cardiovasc Interv Radiol. 2017;40:177–91.CrossRefGoogle Scholar
  5. 5.
    Sutcliffe JA, Briggs JH, Little MW, et al. Antibiotics in interventional radiology. Clin Radiol. 2015;70:223–34.CrossRefPubMedGoogle Scholar
  6. 6.
    Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14:S199–202.CrossRefPubMedGoogle Scholar
  8. 8.
    Wah TM, Irving HC, Gregory W, Cartledge J, Joyce AD, Selby PJ. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int. 2014;113:416–28.CrossRefPubMedGoogle Scholar
  9. 9.
    Burk JF. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery. 1961;50:161–8.Google Scholar
  10. 10.
    Guglielmo BJ, Hohn DC, Koo PJ, Hunt TK, Sweet RL, Conte JE Jr. Antibiotic prophylaxis in surgical procedures: a critical analysis of the literature. Arch Surg. 1983;118:943–55.CrossRefPubMedGoogle Scholar
  11. 11.
    Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70:195–283.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2018

Authors and Affiliations

  • Daniel Crawford
    • 1
  • Eric vanSonnenberg
    • 1
    • 2
    Email author
  • Paul Kang
    • 1
  1. 1.The University of Arizona College of Medicine – PhoenixPhoenixUSA
  2. 2.David Geffen School of Medicine at UCLALos AngelesUSA

Personalised recommendations